Is Nigella Sativa L. (Black Seed) a Phyto-Therapeutic Option in the Treatment of Asthma? A Case Study in Saudi Arabia

Background

Clinical research using herbal medicines requires specific considerations such as the method of production, which leads to chemical and pharmacological variability. Asthma is a leading chronic respiratory disease, remains sub-optimally controlled despite available conventional treatments. Nigella sativa L. (NS) is a herbal medicine traditionally used in asthma and for a multitude of other indications. It has claims associated with a diverse range of major and minor health problems [1] often associated with chronic inflammatory processes [2]. However, rigorous scientific evidence is often lacking.

Publication History

Article published online:
13 June 2022

• References

• 1 Dajani EZ et al.. Overview of the human investigations of Nigella sativa (black seeds): A complementary drug with historical and clinical significance. Gen Int Med Clin Innov 2018; 3
• 2 Gholamnezhad Z et al.. Preclinical and clinical effects of Nigella sativa and its constituent, thymoquinone: A review. J Ethnopharmacol 2016; 190: 372-386
• 3 Koshak AE et al.. Comparative immunomodulatory activity of Nigella sativa L. preparations on proinflammatory mediators: A focus on asthma. Front Pharmacol 2018; 9: 1705
• 4 Koshak AE et al.. Nigella sativa supplementation improves asthma control and biomarkers: A randomized, double-blind, placebo-controlled trial. Phytother Res 2017; 31: 403-409